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ApoptosisThe ﬂuidity of neuronal membranes plays a pivotal role in brain aging and neurodegeneration. In this study,
we investigated the role of the omega-3 fatty acid docosahexaenoic acid (DHA) in modulation of membrane
ﬂuidity, APP processing, and protection from cytotoxic stress. To this end, we applied unilamellar transfer
liposomes, which provided protection from oxidation and effective incorporation of DHA into cell
membranes. Liposomes transferring docosanoic acid (DA), the completely saturated form of DHA, to the
cell cultures served as controls. In HEK-APP cells, DHA signiﬁcantly increased membrane ﬂuidity and non-
amyloidogenic processing of APP, leading to enhanced secretion of sAPPα. This enhanced secretion of sAPPα
was associated with substantial protection against apoptosis induced by ER Ca2+ store depletion. sAPPα-
containing supernatants obtained from HEK-APP cells exerted similar protective effects as DHA in neuronal
PC12 cells and HEK293 control cells. Correlating to further increased sAPPα levels, supernatants obtained
from DHA-treated HEK-APP cells enhanced protection, whereas supernatants obtained from DHA-treated
HEK293 control cells did not inhibit apoptosis, likely due to the low expression of endogenous APP and
negligible sAPPα secretion in these cells. Further experiments with the small molecule inhibitors LY294002
and SP600125 indicated that sAPPα-induced cytoprotection relied on activation of the anti-apoptotic PI3K/
Akt pathway and inhibition of the stress-triggered JNK signaling pathway in PC12 cells. Our data suggest that
liposomal DHA is able to restore or maintain physiological membrane properties, which are required for
neuroprotective sAPPα secretion and autocrine modulation of neuronal survival.ease; AD, Alzheimer's disease;
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The amyloid precursor protein (APP) and its metabolism play
fundamental roles in the pathophysiology of familiar and sporadic
Alzheimer's disease (AD), which presents the most common neuro-
degenerative disorder and one of the leading causes of death in the
elderly. Cleavage of APP at the N-terminus by β-secretase produces
sAPPβ and the membrane-associated C-terminal fragment C99.
Subsequent cleavage of C99 by γ-secretase generates AICD alongwith varying forms of extracellular Aβ [1]. Current research suggests
that oligomeric forms of Aβ have a major impact in AD [1,2]. Under
physiological conditions, the majority of APP is processed by the
activity of α-secretase at the cell surface within the Aβ sequence [3].
α-Secretases belong to the ADAM (a disintegrin and metalloprotease)
family [4] and via their metalloprotease domains, ADAMs are
implicated in ectodomain shedding of many surface molecules (e.g.,
growth factors) and in initiation of intracellular signaling via
regulated intramembrane proteolysis (RIP). ADAMs 9, 10, and 17
have been proposed to act as α-secretases for APP [5]. Proteolytic
cleavage of APP by ADAM enzymes produces a membrane-associated
C-terminal fragment with a size of 83 amino acids (C83) and a 105-
125 kDa soluble and secreted N-terminal APP fragment (sAPPα).
Although altered APP processing and aberrant expression of APP are
known to be crucially involved in the pathophysiology of AD [1,6,7],
the physiological functions of APP and its cleavage products are still
not well understood. However, sAPPα has been reported to have
neurotrophic functions in the central nervous system [7]. Moreover,
accumulating evidence suggests that APP is implicated in regulation of
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the cerebrospinal ﬂuid of AD patients [11–13] and strategies to
improve α-secretase activity may provide neuroprotection [14].
Stimulation of α-secretase activity can be achieved via several
signaling cascades including phospholipase A2 and C, phosphatidy-
linositol 3-kinase or serin/threonin-speciﬁc kinases [4,15,16].
Polyunsaturated fatty acids (PUFAs) are essential for regulating the
ﬂuidity of cell membranes, and there are several lines of evidence that
the ﬂuidity of membranes is important for modulation of APP
processing [17–19]. In the present study, we focused on DHA, which
represents themost abundant PUFA in the brain [20] and is implicated
in various functions including mediation of membrane–protein
interactions [21], gene expression [22], neurogenesis [23–26], and
learning [27–29]. DHA can also exert neuroprotective effects, e.g.,
against neurotoxicity induced by Aβ [30–34].
Recently, we have reported that overexpression of APP protects
PC12 cells against apoptosis triggered by endoplasmic reticulum (ER)
stress and genotoxic stress [10,35]. Furthermore, APP was able to
inhibit stress-triggered activation of the c-Jun N-terminal kinase
(JNK) pathway [10], which represents a central stress signaling
pathway implicated in many paradigms of neuronal and non-
neuronal cell death [36]. Previous studies have also suggested that
the neuroprotective effects of DHAmay be correlated tomodulation of
JNK signaling [31,37], but the functional relevance of APP/sAPPα has
not been addressed in this context. Here, we investigated the
cytoprotective properties of DHA and sAPPα in models of ER Ca2+
store depletion-induced cell death. Our data demonstrate that sAPPα
plays an important role in mediating the protective effects of DHA.
Furthermore, they suggest that autocrine, sAPPα-dependent neuro-
protection involves activation of the pro-survival PI3K/Akt pathway
[38] and inhibition of stress-triggered JNK activation.
2. Materials and methods
2.1. Materials
Unless otherwise stated, all cell culture reagents were obtained
from Gibco/Invitrogen. Trimethylammoniumdiphenylhexatrien
(TMA-DPH), DHA, DA, 3,5-Di-tert-4-butylhydroxytoluene (BHT),
and the PI3K/Akt inhibitor LY294002 were obtained from Sigma-
Aldrich (Taufkirchen, Germany). The caspase substrate acetyl-DEVD-
7-amino-4-methylcoumarin and Thapsigargin were purchased from
Axxora (Lörrach, Germany). The JNK inhibitor SP600125was obtained
from Calbiochem. Lipoid S100® was a kind gift from Lipoid
(Ludwigshafen, Germany).
2.2. Antibodies
C-terminal fragments (CTF) and secreted sAPPα were detected
using monoclonal mouse IgG 6E10 (Signet Laboratories, Cat.9320-02),
which recognizes residues 1–17 of Aβ. Cellular levels of APP were
detected using a polyclonal antibody obtained from Sigma-Aldrich
(A8717). Mouse anti-GAPDH was obtained from Chemicon (Hofheim,
Germany, Cat. MAB374), and rabbit anti-Phospho-JNK was obtained
from Cell Signaling (Cat. 4668). Anti-mouse HRP-conjugated second-
ary antibody was purchased from Calbiochem (Bad-Soden, Germany,
Cat. 401253). Also IRDye800CM-conjugated goat anti-rabbit antibody
and IRDye800CM- or IRDye680CM-conjugated goat anti-mouse
antibody were obtained from LI-COR.
2.3. Preparation of liposomes
Liposomes were prepared as previously described with slight
modiﬁcations [39]. Brieﬂy, phosphatidylcholine (PC) from soy (Lipoid
S100®) was dissolved in dichloromethane (37.7 mg/ml). DHA and DA
were dissolved in ethanol (containing 0.05% BHT) to a ﬁnalconcentration of 5 mmol/l, respectively. Both solutions were mixed
in a ﬂask and dried to a thin ﬁlm by rotation under reduced pressure at
30 °C. Afterwards, the lipid ﬁlm was dried at low pressure in a
desiccator at 4 °C for 12 h. An aliquot of distilled water (5 ml) and
glass beads (5 g) were added to the ﬂask under a stream of N2. The
ﬂask was swiveled for 1 min and then sonicated for 1 min in an
ultrasonic bath at room temperature. This procedure was repeated
three times to producemultilamellar vesicles (MLV). Themixture was
transferred in polycarbonate tubes, andMLVwere pulsative sonicated
for 45 min at 4 °C in the dark using a Branson-Soniﬁer (Typ Cell
Disruptor B15, Firma Branson Ultrasonics Corp) under a stream of N2
to prepare small unilamellar vesicles (SUV). The liposome suspension
was centrifuged at 8000×g for 10 min to remove debris. The
supernatant was removed and centrifuged again at 15,000×g for
5 min. A volume of 4 ml containing SUVs was removed from the top of
the tube and sterile ﬁltered through a 0.22-μm millipore ﬁlter.
Analogically, control liposomes without the addition of fatty acids
were prepared. The size distribution of liposomes was determined
using photon correlation spectroscopy (Zetasizer 3000 HSa, Malvern
Instruments, Malvern,Worcestershire, UK). Incorporation of DHAwas
checked using gas-chromatography and ﬂame ionization detection.2.4. Cell culture
HEK293 cells, stably transfected with human APP695, were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM) at 37 °C
and 5% CO2. The HEK-medium was supplemented with 10% FCS and
penicillin/streptomycin. Geniticin (G418) was added at 3 μg/ml as a
selective antibiotic. Untransfected HEK293 cells were cultured in the
same medium without G418. PC12 cells were cultured with DMEM
with high glucose supplemented with 10% FCS, 5% horse serum, and
penicillin/streptomycin. HEK cells were incubated for 5 days with
liposomes as follows: On day 0, cells were plated and incubated with
control liposomes, liposomes containing DHA (ﬁnal concentration
20 μM) or liposomes containing DA (ﬁnal concentration 20 μM). On
days 2 and 4, media were changed and new liposome solutions were
added. On day 5, media were collected and cells were harvested for
further examinations.2.5. Cytotoxicity
Cytotoxicity in the current study was determined using the MTT
((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay as previously reported [40]. No cytotoxicity was observed for
the concentrations of inhibitors and substances used in the current
study (data not shown).2.6. Determination of lipid peroxidation
Malondialdehyde (MDA) levels were determined using a micro-
plate assay for lipid peroxidation (Lipid PeroxidationMicroplate Assay
Kit FR22; Oxford Biomedical Research, Oxford MI, USA) according to
the manufacturer's instructions. This assay is based on the reaction of
a chromogenic reagent, N-methyl-2-phenylindole, withMDA at 45 °C.
Brieﬂy, cells were cultured in serum containing medium as described
above. Prior to homogenization, cells were washed several times to
remove serum components. Cells were lysed by sonication. To prevent
sample oxidation during preparation, lysis was done in the presence
of 10 μl 0.5 M BHT per 1 ml of cell homogenate. After lysis,
homogenate was centrifuged at 3000×g and 4 °C for 10 min to
remove debris. An aliquot of the sample was saved for protein
determination. The sample was immediately frozen at−70 °C prior to
testing.
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Proteincarbonyl levels were determined using a microplate assay
for protein oxidation (OxiSelect Protein Carbonyl Spectrophotometric
assay STA-315; Cell Biolabs, San Diego, CA, USA) according to the
manufacturer's instructions. Brieﬂy, protein carbonyls in cell homo-
genates were derivatized with dinitrophenylhydrazine (DNPH) ﬁrst.
Proteins were then TCA precipitated, and free DNPH was removed by
washing the protein pellet. After dissolving the protein pellet in
GuHCl, the absorbance of protein-hydrozones was measured at
375 nm, and the protein carbonyls were calculated. Oxidized bovine
serum albumine (BSA) was used as positive control.
2.8. Fatty acid analysis
Fatty acids were analyzed as previously described [41]. Brieﬂy, after
addition of internal standards (C13:0, C17:0, and C19:0), total lipids
were extracted from cell homogenate using methanol/chloroform
(1:2 v/v) and evaporated to dryness. The lipid residuewas reconstituted
and esteriﬁedusingboron triﬂuoride. Fatty acidmethyl esterswere than
subjected to gas-chromatography (Column: BPX70 30 m capillary
column, 0.25 mm id, 0.25-μm ﬁlm thickness) coupled with ﬂame
ionization detection (6890N Agilent GC equipped with a 7683B Auto
injector/Auto sampler), and relative measures were calculated.
2.9. Determination of membrane ﬂuidity in living cells
The membrane ﬂuidity of living cells was determined as earlier
described [42]. The ﬂuorescence polarization probe TMA-DPH
incorporates very rapidly into plasma membranes of cells and is
speciﬁcally localized on the cell surface making its use particularly
appropriate for determining plasma membrane ﬂuidity in living cells
[43]. Cells were washed twice with warm HBSS and supplemented
with 2 μMTMA-DPH. 700,000 cells per vial were incubated at 37 °C for
20 min. The membrane ﬂuorescence polarization was determined
using a SLM Aminco Bowman Series 2 luminescence spectrometer.
The cuvette temperature was 37 °C. The steady-state ﬂuorescence
polarization (Ps) was expressed as the anisotropy (rs) of the probe,
using the following equation: rS=2PS/3−PS. The rS is inversely
correlated to the membrane ﬂuidity, particularly to the acyl-chain
ﬂexibility of phospholipids.
2.10. Measurement of mitochondrial membrane potential
The mitochondrial membrane potential (MMP) in living cells was
determined using Rhodamin123 as ﬂuorescence probe with slight
modiﬁcations as previously described [44]. Brieﬂy, cells were incubated
in the dark for 15 min with 0.4 μM R123 on a horizontal shaker. Cells
were twice both centrifuged (1500 rpm, 5 min) and washed with HBSS
buffer (supplementedwithMg2+, Ca2+ andHEPES, pH 7.4, 37 °C). After
supplementing cells with new HBSS, MMP was assessed by ﬂow
cytometry (FACSCalibur) using Cell Quest software (BD Biosciences).
2.11. Determination of cellular ATP levels
Cellular levels of adenosine-triphosphate (ATP) were determined
using a chemiluminescence-based kit (Vialight Plus, Lonza, Rockland,
USA)according tomanufacturer's instructionaspreviouslydescribed [44].
2.12. Western blot analysis
Total protein levels were determined by the Lowry method. The
samples were generated by adding an appropriate volume of lysis
buffer (68.5 mM Tris/HCl pH 6.8, 2% SDS, 10% glycerol, and protease
and phosphatase inhibitor) to the cells. Then the cells were
immediately scraped off the plates and transferred to a microcen-trifuge tube and sonicated. 50 μg protein samples were loaded onto 8%
or 12% SDS-polyacrylamide gels. For the detection of released sAPPα,
the conditioned medium was collected and the values were
normalized to the cell lysate protein concentration. Proteins were
separated at 160 V and then blotted to nitrocellulose membranes
(Protean BA83, 2 μm, Whatman, Dassel, Germany) in Towbin buffer
(25 mM Tris, 192 mM glycine, 20% methanol (v/v) and 0.01% SDS) at
70 mA for 1 h. The blots were blocked in blocking buffer (5% non-fat
milk powder, 15 mM Tris/HCl pH 7.5, 200 mM NaCl, and 0.1% Tween
20) at room temperature for 1 h. For detection of the activated JNK1
and JNK2, we diluted the rabbit polyclonal anti P-JNK antibody 1:1000
in Tris-buffered saline (TBS) containing 5% BSA and 0.1% Tween 20
and incubated the blots overnight at 4 °C. APP and sAPPα levels were
detected by diluting the appropriate antibody 1:500 in TBS-containing
3% non-fat milk powder and 0.1% Tween 20. Even these blots were
incubated overnight at 4 °C. Primary antibodies were detected by
subsequent incubation with IRDye800CW anti-rabbit or IRDye680CW
anti-mouse or anti-rabbit in blocking solution for 1 h at room
temperature. The Odyssey Infrared Imaging System (LI-COR) was
used for visualizations and quantiﬁcations.
2.13. ELISA detection of sAPPα
For the quantitative analysis of sAPPα, ﬁve million HEK-APP and
HEK293 control cells were plated in 10-cm dishes. Conditioned,
serum-free media were collected after 24 h and supernatants were
centrifuged at 200×g for 4 min to eliminate cell debris. Soluble sAPPα
was quantiﬁed using the IBL human sAPPα colorimetric sandwich
ELISA Kit (IBL Immuno-Biological Laboratories, Hamburg, Germany)
according to the supplier's instructions.
2.14. Caspase-3-like protease activity (DEVDase assay)
For measurement of caspase-3-like protease activity, cells were
lysed in 200 μl lysis buffer [10 mM HEPES, pH7.4, 42 mM KCl, 5 mM
MgCl2, 1 mM phenylmethylsulfonyl ﬂuoride (PMSF), 0.1 mM EDTA,
0.1 mMEGTA, 1 mMDTT, 1 μg/ml pepstatin A, 1 μg/ml leupeptin, 5 μg/
ml aprotinin, 0.5% 3-(3-cholamidopropyldimethylammonio)-1-pro-
pane sulfonate (CHAPS)]. 50 μl of this lysate was added to 150 μl
reaction buffer (25 mM HEPES, pH7.5, 1 mM EDTA, 0.1% CHAPS, 10%
sucrose, 3 mM DTT) and 10 μM of the ﬂuorogenic substrate Ac-DEVD-
AMC. This substrate is cleaved by caspase 3, and also by the caspases 6,
7, 8, and 10. Accumulation of Acetyl-DEVD-7-amido-4-methylcou-
marin (AMC) ﬂuorescence was monitored over 2 h using an Htsoft
Tecan Genios multiplate reader (excitation 360 nm, emission
465 nm). Fluorescence of blanks containing only lysis buffer was
subtracted from the values. Protein content was determined using the
Roti®quant (Karl-Roth GmbH, Karlsruhe, Germany). Caspase activity
is expressed as change in ﬂuorescent units per microgram protein and
per hour.
2.15. Statistics
All experimentsweredoneat least in three independent experiments,
and all assays were done in triplicates or quadruplicates. Statistical
analyses were performed using one-way ANOVA followed by a Tukey
comparison test. All data were expressed as the means±SEM. The
correlations were calculated using SPSS (IBM).
3. Results
3.1. DHA enhances membrane ﬂuidity and sAPPα secretion in HEK-APP
cells
In our experimental approach, cells were incubated with uni-
lamellar transfer liposomes containing DHA to provide effective
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malondialdehyde (Fig. 1A) and of proteincarbonyls (Fig. 1B) were
unchanged, conﬁrming that the polyunsaturated fatty acids in our
liposomal DHA preparations were protected from oxidation [46,47].
The cells were also incubated with pure liposomes (LS) or liposomes
containing DA, which served as controls. As to be expected, incubation
of HEK-APP cells with LS or DA (20 μM) for 5 days had no effect on
cellular DHA levels (Fig. 1C). In contrast, incubation of cells with DHA
(20 μM) resulted in potently elevated DHA levels (+420%) (Fig. 1C).
Order parameters of biological membranes are decreased by the
incorporation of DHA [48]. Accordingly, enhanced cellular DHA levels
were accompanied by signiﬁcantly enhanced membrane ﬂuidity in
living cells as determined by decreased TMA-DPH anisotropy values
(Fig. 1D).
Levels of released sAPPα in supernatants of untransfected HEK293
control cells and APP overexpressing HEK293 cells were analyzed by
Western blot and ELISA. The cells were seeded at equal densities and
maintained in culture for 24 h. HEK-APP cells secreted signiﬁcant
levels of sAPPα (Fig. 1E), with the average concentration reachingFig. 1. DHA enhances membrane ﬂuidity and anti-amyloidogenic processing of the amylo
liposomes (LS), liposomes containing 20 μM DA or 20 μM DHA or were left untreated (co
protein) were assessed spectrophotometrically after reaction with a chromogenic reagen
derivatization with dinitrophenylhydrazine. The amount of protein-hydrozone was meas
determined using gas chromatography with ﬂame ionization detection (n=4, means±SE
anisotropy of the ﬂuorescence probe TMA-DPH, were determined using ﬂuorescence polariz
signiﬁcant amounts of sAPPα in the supernatant compared to untransfected HEK293 contro
blot analysis in cell lysates and supernatants. The antibody directed against APP recogniz
~130 kDa) and sAPPα in the cell culture supernatant. GAPDH served as a loading control. (F
fragments of APP (CTF99) in whole cell lysates using Western blot analysis after 5 days of in
loading control.70 ng/ml after 24 h (Fig. 1E). Western blot analysis revealed that
secretion of sAPPα and expression of intracellular APP was conspic-
uously lower in HEK293 control cells (Fig. 1F). Incubation of HEK-APP
cells with DHA (20 μM) for 9 days further elevated the levels of sAPPα
in the cell culture media (Fig. 1F). Concurrently, the β-secretase-
related 99-residue membrane-associated C-terminal fragment C99
was clearly reduced (Fig. 1F), indicating a shift towards α-secretase
processing of APP.
3.2. DHA protects HEK-APP cells from ER Ca2+ store depletion
In light of the fact that disturbances of Ca2+ homeostasis play a
pivotal role in AD [49], we were interested whether DHA could protect
cells from Ca2+ store depletion and cell death. Inhibition of the sarco/
endoplasmic reticulum Ca2+-ATPase (SERCA) by Thapsigargin (1 μM)
signiﬁcantly reduced the mitochondrial membrane potential (MMP)
andATP levelsofHEK-APPcells,whichhadbeenpreincubatedwithpure
LS or LS containing DA (20 μM) for 5 days. (Fig. 2A, B). Cells incubated
with LS containing DHA (20 μM) were protected from Thapsigargin-id precursor protein in HEK-APP cells. HEK-APP cells were incubated for 5 days with
n). (n=4–6) (means±SEM; ***pb0.001). (A) Levels of malondialdehyde (nmol/mg
t at 586 nm. (B) Protein carbonyl levels (nmol/mg protein) were determined after
ured spectrophotometrically at 375 nm. (C) Levels of DHA [mg/g wet weight] were
M; ***pb0.001). (D) Changes in membrane ﬂuidity, which inversely correlates to the
ation spectroscopy in living cells. (E) HEK-APP cells expressing human APP695 release
l cells as measured by ELISA analysis (n=3) (means±SEM; *pb0.05) and by Western
es all three isoforms in the cell lysates (immature ~110 kDa, sAPP ~120 kDa, mature
) Levels of sAPPα were measured in cell culture supernatants and levels of C-terminal
cubation with empty liposomes or liposomes containing DHA or DA. GAPDH served as a
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Fig. 2. DHA protects cells from ER Ca2+ store depletion. HEK-APP cells were incubated with liposomes (LS), liposomes containing 20 μM DA or 20 μM DHA for 5 days. Twenty-four
hours before the end of treatment, cells were additionally treated with 1 μM Thapsigargin (Tha). (A) Mitochondrial membrane potentials (MMP) were determined using the
ﬂuorescence probe Rhodamin123 and FACS analysis. Values were normalized to untreated HEK-APP cell cultures (n=6; means±SEM; *pb0.05; **pb0.01). (B) ATP levels were
determined using a chemiluminescence-based assay kit. Values were normalized to untreated HEK-APP cell cultures (n=6; means±SEM; **pb0.01; ***pb0.001). (C) Caspase-3
activity was determined by DEVD cleavage assay (n=4) after 5 days of incubation with liposomes. Thapsigargin was added for the ﬁnal 16 h of incubation at a concentration of 1 μM
(AU, arbitrary ﬂuorescence units) (means±SEM; *pb0.05; #pb0.05).
240 G.P. Eckert et al. / Biochimica et Biophysica Acta 1808 (2011) 236–243induced MMP reduction and ATP depletion (Fig. 2A, B). Thapsigargin
treatment (1 μM) of HEK-APP cells incubated with LS or DA was
associated with signiﬁcantly enhanced effector caspase activity,
indicating induction of apoptotic cell death (Fig. 2C). In analogy to its
effects on stabilizing ATP levels and MMP, cells incubated with DHA
(20 μM) were also protected from Thapsigargin-induced effector
caspase activation (Fig. 2C).
3.3. sAPPα plays an essential role for the protective effects of DHA
Based on the observation that increased secretion of sAPPα in
HEK-APP cells was associated with enhanced protection after DHA
treatment (Fig. 2), we speculated that the protective effects of DHA
indeed required sAPPα. To address this question, HEK293 cells were
incubated with conditioned supernatants of HEK293 cells or HEK-APP
cells that had been treated for 5 days either with LS alone or with LS
containing DHA (20 μM), respectively. Again, HEK293 cells incubated
with sAPPα-containingmedia obtained from untreated HEK-APP cells
were signiﬁcantly less vulnerable against Ca2+ store depletion in
comparison to cells incubatedwithmedia fromHEK293 cells (Fig. 3A).
This protective effect against Thapsigargin-triggered stress was
further enhanced when supernatants of DHA-treated HEK-APP cells
were applied to the cultures (Fig. 3A). In contrast, supernatants
obtained from DHA-treated HEK293 control cells did not elicit any
neuroprotective effects in HEK293 cells, indicating that DHA did not
stimulate secretion of sAPPα or other neuroprotectants in sufﬁcientamounts to be detectable in our assays into the culture medium
(Fig. 3A). Of note, the protective effects obtained with supernatants of
DHA-treated HEK-APP cells were very similar to those observed when
we directly treated HEK-APP cells with DHA (Fig. 2C). Collectively,
these data suggest that sAPPα indeed plays an essential role in the
protective effects of DHA.
3.4. Protective mechanisms of sAPPα involve modulation of the PI3K/Akt
and JNK signaling pathways
To conﬁrm the observed cytoprotective effects of sAPPα-contain-
ing supernatants in a neuronal cell model, we applied PC12 cells
[10,35]. Cells were preincubated with conditioned culture super-
natants collected from untreated HEK293 control cells and HEK-APP
cells (Fig. 1C and D) after which they were challenged with
Thapsigargin (1 μM) for 16 h. Activation of effector caspases was
determined by cleavage of a ﬂuorogenic substrate using the DEVDase
assay [50]. PC12 cells incubated with conditioned media from HEK-
APP cells were signiﬁcantly less vulnerable against ER Ca2+ store
depletion compared to cultures incubated with conditioned media
from HEK293 cells (Fig. 3B, C). Our previous studies had suggested an
important role of APP/sAPPα in the control of JNK/c-Jun signaling in
response to cytotoxic stress triggered by UV irradiation [10]. To
further investigate the molecular mechanisms of sAPPα-mediated
neuroprotection, we analyzed its effects on the JNK stress signaling
pathway and on the PI3K/Akt survival pathway in the experimental
Fig. 3. Protectivemechanisms of DHA aremediated by sAPPα. (A) HEK293 cells and HEK-APP cells were incubatedwith empty liposomes (white bars) or liposomes containing 20 μM
DHA (black bars) for 5 days. HEK293 cells were incubated with the supernatants of these cultures in parallel to the treatment with Thapsigargin (1 μM) for 48 h. HEK293 c.m.
indicates treatment with conditioned media derived from HEK293 control cells treated with either LS or DHA, whereas con HEK-APP c.m. indicates treatment with conditioned
media derived from HEK-APP cells treated with LS or DHA. Caspase-3 activity was determined by DEVD cleavage assay (n=4) (means±SEM; #pb0.05). (B and C) Protective effects
of sAPPα involve the PI3K/Akt pathway and inhibition of the JNK pathway as analyzed with the small-molecule inhibitors LY294002 (10 μM) and SP600125 (200 nM). Cultures of
PC12 cells were preincubated with conditioned media of HEK con cells (con) or HEK-APP cells (sAPPα) for 24 h. After further preincubation with or without LY294002 or SP600125
(2 h), cells were treated with Thapsigargin (1 μM) for 16 h. Caspase-3 activity was determined by the DEVD cleavage assay (n=4) (means±SEM, *pb0.05; #pb0.05; n.s.=not
signiﬁcant). (D) Thapsigargin-dependent phosphorylation of JNK is decreased after treatment of PC12 cells with sAPPα-containing supernatant as assayed byWestern blot analysis.
GAPDH served as a loading control. PC12 cells were treated for 6 h with 1 μM Thapsigargin.
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cells preincubated with conditioned supernatants of HEK293 control
(con) and HEK-APP (sAPPα) cells were also treated with Thapsigargin
in the presence or absence of the PI3K/Akt pathway inhibitor
LY294002. Interestingly, LY294002 completely abolished the protec-
tive effects of sAPPα on apoptosis induced by Ca2+ store depletion
(Fig. 3C). Conversely, inhibition of the JNK signaling cascade with the
synthetic inhibitor SP600125 in PC12 cells preincubated with
conditioned supernatants of HEK293 control cells was able to mimic
the protective effects of sAPPα (Fig. 3B). Accompanying Western blot
analysis demonstrated that both basal and Thapsigargin-induced JNK
phosphorylation was reduced in PC12 cells incubated with sAPPα-
containing media (Fig. 3D). Taken together, these data suggest that
the protective effects of sAPPα are associated with activation of the
PI3K signaling pathway and inhibition of the stress-activated JNK
signaling pathway.
4. Discussion
Changes in the ﬂuidity of neuronal membranes are associated with
brain aging and play a central role in Alzheimer's disease [19,51,52].The essential omega-3 fatty acids DHA and arachidonic acid are the
major PUFAs in the brain [53]. PUFAs represent major components of
biological membranes, and it was suggested that alterations in the
architecture and function of cell membranes might contribute to the
beneﬁcial impact of n–3 PUFAs on cognitive functions [54–56]. There
are several lines of evidence that dietary DHA can lower cognitive
decline, Aβ formation, and synaptic degeneration in transgenic AD
mouse models [31,32,57–60]. There is also abundant evidence that
the metabolism of APP can be greatly affected by aging-associated
changes in the membrane ﬂuidity of cells [17,18,61].
Here, we studied the effects of DHA on APP processing and cell
survival in APP-overexpressing HEK293 cells and neuronal PC12 cells.
The ﬂuidizing effects of DHA on membranes were previously
described in cultured retinoblastoma cells [62] and in synaptosomal
plasma membranes isolated from brains of Aβ-infused rats ex vivo
[63]. We and others recently reported that cleavage of APP strongly
depends on membrane properties and that enhanced membrane
ﬂuidity favors the non-amyloidogenic pathway of APP processing
[18,19]. Accordingly, Sahlin et al. demonstrated that DHA stimulates
the non-amyloidogenic APP processing in cellular models of AD [33].
In line with these ﬁndings, we demonstrate herein that liposomal
242 G.P. Eckert et al. / Biochimica et Biophysica Acta 1808 (2011) 236–243DHA is capable to increase the ﬂuidity of cell membranes, thereby
enhancing generation of sAPPα, which is known to exert autocrine
and paracrine effects in neuronal and non-neuronal cells.
In previous studies, we reported that in the brain of guinea pigs
treated with plant-derived omega-3 fatty acids, the levels of oleic,
linoleic, arachidonic, and DHA were signiﬁcantly enhanced and that
dissociated brain cells isolated from these animals were less vulnerable
against nitrosative stress as indicated by stabilized mitochondrial
function and enhanced levels of ATP [41]. Here, we report that DHA
protects HEK-APP cells against Thapsigargin-induced mitochondrial
dysfunction, ATP depletion, and effector caspase activation, three
hallmarks of apoptotic cell death. To address the question whether
sAPPα secreted into the culture medium of DHA-treated cells was
responsible for the observed protection, we compared the effects of
supernatants obtained from DHA-treated HEK-APP cells and DHA-
treated HEK293 control cells, respectively. In contrast to HEK-APP cells,
HEK293 control cells displayed low expression of endogenous APP and
negligible sAPPα secretion, and their supernatants did not provide any
cytoprotection. We also demonstrated that stimulation of sAPPα
secretion by DHA further enhanced the protective capacity of super-
natants obtained from HEK-APP cells. From these observations, we
collectively conclude that enhanced sAPPα generation signiﬁcantly
contributes to the cytoprotection mediated by DHA.
Since the JNK signaling pathway is an important mediator of
stress-triggered neuronal cell death, which is activated in response to
many pathophysiological stress stimuli implicated in neurodegenera-
tion [10,64], we also analyzed whether sAPPα-mediated protection
may be associated with alterations in the extent of JNK activation.
Indeed, stress-triggered JNK phosphorylation was partly inhibited by
sAPPα. As demonstrated here and elsewhere [10], sAPPα had similar
protective effects after UV irradiation, suggesting that sAPPα can
antagonize distinct upstream stress stimuli linked to activation of the
common JNK stress signaling cascade.
There is a potential crosstalk between the pro-survival PI3K/Akt
pathway and the JNK pathway, as Akt can inhibit JNK signaling by
phosphorylation of the JNK upstream kinase MLK3 [65]. It was also
suggested that wild-type APP, but not mutant APP, can activate the
PI3K/Akt pathway [66]. Of note, the PI3K/Akt pathway inhibitor
LY296002 completely abolished the ability of sAPPα to protect PC12
cells from Thapsigargin-induced cell death, suggesting that constitu-
tive activation of the PI3K/Akt pathway might be of central relevance
for the observed neuroprotective effects of sAPPα and may promote
survival under various stress conditions. Interestingly, sAPPα was
shown to enhance the biogenesis of the neuroprotective, DHA-
derived lipid messenger neuroprotectin D1 (NPD1) [67], which was
previously proposed to mediate its neuroprotective effects via the
PI3K/Akt pathway [68].
Collectively, our data suggest that omega-3 fatty acidsmay restore or
maintain physiological membrane properties, which are required for
neuroprotective sAPPα secretion. Enhancing α-secretase processing of
APP via physiological modulators of membrane ﬂuidity appears to be a
feasible approach for the early prevention of AD [69–71].
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